Advertisement
Advertisement
CNSY
C
Cerenome, Inc. Common Stock
3.08
USDSponsored
+0.13
+4.22%
Aug 25, 15:57 UTC -4
Closed
Pre-Market
3.08
0.00
0.00%
CNSY Earnings Reports
Positive Surprise Ratio
CNSY beat 0 of 1 last estimates.
0%
Next Report
Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.49M
/-$0.91
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/-9.00%
Cerenome, Inc. Common Stock earnings per share and revenue
On Aug 12, 2026, CNSY reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.92 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.13 million, with a --% difference.
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.91 USD, with revenue projected to reach 1.49 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Elutia Inc. Class A Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.15
Actual
-$0.17
Surprise
-11.11%
Lantern Pharma Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.28
Surprise
+27.76%
EVOGENE LTD.
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.13
Surprise
+52.80%
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
Cabaletta Bio, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.34
Surprise
+10.69%
Abeona Therapeutics Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.23
Actual
-$0.35
Surprise
-49.19%
Prenetics Global Limited Class A Ordinary Share
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.71
Actual
-$0.53
Surprise
+26.30%
Fate Therapeutics, Inc.
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.25
Surprise
+8.49%
ProMIS Neurosciences Inc. Common Shares (ON)
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$1.39
Actual
-$1.28
Surprise
+8.07%
TuHURA Biosciences, Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+5.34%
FAQ
What were Cerenome, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Cerenome, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Cerenome, Inc. Common Stock's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Cerenome, Inc. Common Stock expected to report next?
The next earning report is scheduled for Oct 28, 2026.
What are the forecasts for Cerenome, Inc. Common Stock's next earnings report?
Based on --
analysts, Cerenome, Inc. Common Stock is expected to report EPS of -$0.91 and revenue of $1.49M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement